Dawn Homer

Summary

Affiliation: University Hospital Birmingham
Country: UK

Publications

  1. ncbi Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction
    Dawn Homer
    Department of Rheumatology, Selly Oak Hospital, University Hospital Birmingham NHS Foundation Trust, UK
    Musculoskeletal Care 7:78-92. 2009
  2. ncbi Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: A case series from a local surveillance of serious adverse events
    Paresh Jobanputra
    Department of Rheumatology, Selly Oak Hospital, University Hospital Birmingham NHS Foundation Trust, Raddlebarn Road, Birmingham, B29 6JD, UK
    BMC Musculoskelet Disord 9:48. 2008
  3. ncbi Monitoring and assessing the safety of disease-modifying antirheumatic drugs: a West Midlands experience
    Paresh Jobanputra
    Department of Rheumatology, Selly Oak Hospital, University Hospital Birmingham NHS Trust, Selly Oak, Birmingham, United Kingdom
    Drug Saf 25:1099-105. 2002
  4. ncbi Patient self-injection of methotrexate for inflammatory arthritis: a study evaluating the introduction of a new type of syringe and exploring patients' sense of empowerment
    Jennifer Hiley
    University Hospital Birmingham NHS Foundation Trust, Birmingham, UK
    Musculoskeletal Care 6:15-30. 2008
  5. ncbi A study of parenteral use of methotrexate in rheumatic conditions
    Valerie Arthur
    Rheumatology Department, University Hospital Birmingham NHS Trust, Selly Oak Hospital, Birmingham, UK
    J Clin Nurs 11:256-63. 2002

Collaborators

Detail Information

Publications5

  1. ncbi Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction
    Dawn Homer
    Department of Rheumatology, Selly Oak Hospital, University Hospital Birmingham NHS Foundation Trust, UK
    Musculoskeletal Care 7:78-92. 2009
    ..In this randomized trial we tested the feasibility of giving patients, who were about to start on a DMARD, information about the drug in groups and compared this with information given individually...
  2. ncbi Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: A case series from a local surveillance of serious adverse events
    Paresh Jobanputra
    Department of Rheumatology, Selly Oak Hospital, University Hospital Birmingham NHS Foundation Trust, Raddlebarn Road, Birmingham, B29 6JD, UK
    BMC Musculoskelet Disord 9:48. 2008
    ..We report an investigation from a local surveillance for serious adverse drug reactions associated with disease modifying anti-rheumatic drugs that was triggered by the occurrence of liver failure in two of our patients...
  3. ncbi Monitoring and assessing the safety of disease-modifying antirheumatic drugs: a West Midlands experience
    Paresh Jobanputra
    Department of Rheumatology, Selly Oak Hospital, University Hospital Birmingham NHS Trust, Selly Oak, Birmingham, United Kingdom
    Drug Saf 25:1099-105. 2002
    ..We describe preliminary data from a regional surveillance scheme. Our aims were to identify a broad range of potential adverse events, to identify deficiencies in care and examine the management of common events in order to improve care...
  4. ncbi Patient self-injection of methotrexate for inflammatory arthritis: a study evaluating the introduction of a new type of syringe and exploring patients' sense of empowerment
    Jennifer Hiley
    University Hospital Birmingham NHS Foundation Trust, Birmingham, UK
    Musculoskeletal Care 6:15-30. 2008
    ..To evaluate the introduction of a new type of syringe for patients on a self-injection of methotrexate (MTX) programme and explore patients' sense of empowerment relating to the self-injection of MTX...
  5. ncbi A study of parenteral use of methotrexate in rheumatic conditions
    Valerie Arthur
    Rheumatology Department, University Hospital Birmingham NHS Trust, Selly Oak Hospital, Birmingham, UK
    J Clin Nurs 11:256-63. 2002
    ..Patients were able to administer safely methotrexate subcutaneously. Self-administration reduced hospital visits, was more convenient for patients and improved patient satisfaction...